Lisata Therapeutics Inc (LSTA)
2.81
+0.04
(+1.44%)
USD |
NASDAQ |
May 07, 16:00
2.81
0.00 (0.00%)
After-Hours: 20:00
Lisata Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2016 | 0.7657 |
| December 31, 2015 | 0.7074 |
| September 30, 2015 | 0.3036 |
| June 30, 2015 | 0.2582 |
| March 31, 2015 | 0.3318 |
| December 31, 2014 | 0.2844 |
| September 30, 2014 | 0.2691 |
| June 30, 2014 | 0.0633 |
| March 31, 2014 | 0.082 |
| December 31, 2013 | 0.0663 |
| September 30, 2013 | 0.1131 |
| June 30, 2013 | 0.1149 |
| March 31, 2013 | 0.1253 |
| December 31, 2012 | 0.1149 |
| September 30, 2012 | 0.0763 |
| June 30, 2012 | 0.081 |
| March 31, 2012 | 0.3108 |
| December 31, 2011 | 0.061 |
| September 30, 2011 | 0.2073 |
| June 30, 2011 | 0.3601 |
| March 31, 2011 | 0.2964 |
| December 31, 2010 | 0.259 |
| September 30, 2010 | 0.3203 |
| June 30, 2010 | 0.3924 |
| March 31, 2010 | 0.7435 |
| Date | Value |
|---|---|
| December 31, 2009 | 0.5014 |
| September 30, 2009 | -0.0809 |
| June 30, 2009 | 0.0102 |
| March 31, 2009 | -1.526 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.0174 |
| June 30, 2008 | 0.0424 |
| March 31, 2008 | 0.0506 |
| December 31, 2007 | 0.0087 |
| September 30, 2007 | 0.0245 |
| June 30, 2007 | 1.036 |
| March 31, 2007 | 0.1754 |
| December 31, 2006 | 0.8442 |
| September 30, 2006 | 0.1724 |
| June 30, 2006 | -0.7561 |
| March 31, 2006 | -0.8766 |
| December 31, 2005 | -0.1924 |
| September 30, 2005 | -0.2568 |
| June 30, 2005 | -0.2736 |
| March 31, 2005 | -0.2635 |
| December 31, 2004 | -0.2946 |
| September 30, 2004 | -0.3948 |
| June 30, 2004 | -0.2832 |
| March 31, 2004 | -0.284 |
| December 31, 2003 | -0.2725 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Becton Dickinson & Co | 0.7022 |
| Edwards Lifesciences Corp | 0.0839 |
| AIM ImmunoTech Inc | 0.00 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 54.69M |
| Total Liabilities (Quarterly) | 6.80M |
| Shareholders Equity (Quarterly) | 48.15M |